Back to Search
Start Over
The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation.
- Source :
-
Haematologica [Haematologica] 2017 May; Vol. 102 (5), pp. e191-e194. Date of Electronic Publication: 2017 Jan 25. - Publication Year :
- 2017
- Subjects :
- Adenine analogs & derivatives
Animals
Biomarkers
Humans
Mice
Neutrophil Activation immunology
Neutrophils immunology
Piperidines
Respiratory Burst drug effects
Respiratory Burst genetics
Respiratory Burst immunology
Triggering Receptor Expressed on Myeloid Cells-1 metabolism
Neutrophil Activation drug effects
Neutrophil Activation genetics
Neutrophils drug effects
Neutrophils metabolism
Protein Kinase Inhibitors pharmacology
Pyrazoles pharmacology
Pyrimidines pharmacology
Triggering Receptor Expressed on Myeloid Cells-1 genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 102
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Report
- Accession number :
- 28126969
- Full Text :
- https://doi.org/10.3324/haematol.2016.152017